Could Orphan Drugs Turn Health Economics on
When is $100,000 a year more expensive than $500,000 a year? The answer: when
Supremes to Hear Case on Affordable Care
The legal challenges to the Affordable Care Act commenced just as soon as the
Stem Cell Therapy FDA Approved for Wrinkles
The treatment, called laViv, was developed by Fibrocell Science of Exton, Pa. The treatment,
Junk in the Trunk: Amateur Buttock Enhancements
The arrest of a Florida man for allegedly performing buttock injections with a variety
TEDxCambridge 2011 Twitter Feed
I’m at TEDxCambridge today. Should be interesting. Follow along on Twitter at #TEDxC or
US FTC Commissioner Doubts Benefits of ACOs
This is a different version from what we hear in the news but if
Yanking Avastin’s Breast Cancer Indication –the Right
As expected the FDA today removed Avastin’s approval for use as a breast cancer
Can EMRs Do More Harm than Good?
Apparently yes, according to this New York Times report: Apparently yes, according to this
Vaccines in the Pipeline and Vaccine Economics
EXCLUSIVE ARTICLE – The last three of these posts touched on a variety of
ACO Update: A Third Horse Enters the
A few months ago, we noted that the release of regulations for ACOs would